MedPath

ONO-2910-02: A Phase IIa Study of ONO-2910 in Patients with Diabetic Polyneuropathy

Phase 2
Conditions
Diabetic polyneuropathy
Registration Number
JPRN-jRCT2061210008
Lead Sponsor
Hirashima Yoshinori
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
168
Inclusion Criteria

1. Type 2 diabetes with HbA1c : >= 6.5%, <= 10.0%
2. Patients diagnosised with diabetic polyneuropathy (DPN) by simplified diagnostic criteria for diabetic polyneuropathy proposed by the Conference on Diabetic Polyneuropathy
3. Patients suffering from Numbness and Tingling on both feet and their mTCNS score are >= 2 each.

Exclusion Criteria

1. Patients who are expected to change treatment methods (drug therapy, exercise therapy, etc.) for diabetes during the study period
2. Patients who are expected to newly take or change the dosage and administration of peripheral neuropathic pain medication, other analgesics, or agents for overall symptoms of DPN during the study period
3. Patients with pain or numbness other than DPN in upper or lower limbs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath